Vice President, Health Economics & Market Access (HEMA), Neuromodulation

Boston Scientific•Maple Grove, MN
•$225,900 - $429,200•Hybrid

About The Position

Boston Scientific is seeking a strategic leader to serve as Vice President, Health Economics & Market Access (HEMA) for Neuromodulation. As a member of the Neuromodulation Leadership Team, this leader defines and leads the global HEMA strategy, integrating market access, reimbursement, health economics, evidence generation, and value communication across portfolio strategy, product development, commercialization, and lifecycle management. The Vice President partners with global, regional, and functional teams to expand patient access, support adoption of innovative therapies, demonstrate clinical and economic value, and drive sustainable business growth. The role builds and develops a high-performing global HEMA organization and shapes future market access capabilities across the Neuromodulation franchise. The position is based in Maple Grove, Minnesota (Arbor Lake), with a hybrid work schedule and approximately 30% travel, depending on business needs.

Requirements

  • Bachelor's degree in health economics, public health, business, life sciences, or a related field.
  • At least 15 years of progressive experience in Health Economics, Market Access, reimbursement, health policy, or related healthcare disciplines.
  • At least 10 years of leadership experience, including leading global teams and senior professionals.
  • Proven success developing and executing global HEMA strategies that advance patient access, evidence generation, therapy adoption, and commercial growth.
  • Deep knowledge of global healthcare systems, reimbursement environments, and market access requirements, including strong expertise in U.S. payer, coverage, coding, and payment systems.
  • Experience integrating market access and health economics strategies into product development, evidence generation, commercialization, and lifecycle management.
  • Significant medical device or medical technology industry experience and a strong understanding of global MedTech business operations.
  • Demonstrated ability to influence, lead, and drive results within complex, global matrix organizations.
  • Track record of building high-performing teams, developing talent, and leading organizational capability growth.
  • Strong executive presence and communication skills, including ability to translate complex healthcare, reimbursement, and economic insights into business strategy and action.
  • Significant experience communicating with senior internal leaders and external stakeholders.
  • Based in Maple Grove, Minnesota (Arbor Lake), with a hybrid work schedule.
  • Approximately 30% travel, depending on business needs.

Nice To Haves

  • Advanced degree (MBA, MPH, MHA, MS, PhD, PharmD, JD, or equivalent) in a relevant discipline.
  • Experience in Neuromodulation, implantable medical devices, pain management, or related therapeutic areas, with understanding of reimbursement, evidence, and patient-access dynamics associated with implantable therapies.
  • Experience developing market access and evidence strategies for physician- and/or procedure-based therapies across hospital, ambulatory, and other sites of care.
  • Experience working with health technology assessment bodies, government agencies, payers, and global market access organizations.

Responsibilities

  • Define and lead the global HEMA vision and strategy for the Neuromodulation portfolio, aligned with business objectives and growth priorities.
  • Serve as a strategic member of the Neuromodulation Leadership Team, advising on market access, reimbursement, health policy, healthcare economics, and payer and provider dynamics.
  • Establish HEMA priorities, investments, and success measures that support patient access, therapy adoption, and commercial performance.
  • Drive alignment and execution of HEMA strategies across Neuromodulation and the broader enterprise.
  • Integrate market access, reimbursement, health economics, and evidence strategies into portfolio planning, product development, commercialization, and lifecycle management.
  • Lead global HEMA strategies for new and existing Neuromodulation therapies, including coverage, coding, payment, evidence generation, and value communication.
  • Partner across functions to identify opportunities, mitigate access risks, and support product launches, therapy expansion, new indications, and business development activities.
  • Ensure payer, provider, and healthcare system perspectives inform portfolio prioritization and investment decisions.
  • Lead global market access strategies that support coverage, coding, payment, and adoption of Neuromodulation therapies.
  • Provide expertise in global reimbursement environments, payer expectations, health technology assessment, healthcare policy, and U.S. coverage, coding, and payment pathways.
  • Partner with regional teams to translate global strategies effectively to local healthcare systems and market requirements.
  • Engage payers, healthcare providers, policymakers, professional societies, and other healthcare decision-makers to advance patient access and reimbursement objectives.
  • Establish evidence-generation and health economics priorities that demonstrate the clinical, economic, patient, and healthcare system value of Neuromodulation therapies.
  • Partner with Clinical, Medical Affairs, R&D, and other functions to develop evidence strategies addressing payer, provider, health system, and policy needs.
  • Oversee development of economic analyses, real-world evidence, value propositions, reimbursement resources, and customer value tools.
  • Translate complex health economic, reimbursement, and market access insights into actionable business recommendations and compelling value communications.
  • Partner with regional, field, and commercial teams to support product launches, therapy adoption, customer engagement, and market access execution.
  • Use patient, provider, payer, and healthcare system insights to inform portfolio strategy, evidence development, and commercialization plans.
  • Equip customer-facing teams with reimbursement, health economics, and value communication resources that support appropriate patient access and therapy adoption.
  • Support strategic engagement with healthcare systems, payers, government stakeholders, healthcare providers, and key opinion leaders.
  • Lead, develop, and inspire a global HEMA organization focused on market access, reimbursement, evidence generation, health economics, and value communication.
  • Build organizational capabilities, operating models, and governance that support evolving Neuromodulation business needs.
  • Attract, develop, and retain talent while building a strong leadership and succession pipeline.
  • Foster collaboration and influence across a complex, global matrixed organization.
  • Establish governance, processes, and operating standards for effective execution of HEMA strategies.
  • Ensure HEMA activities comply with applicable legal, regulatory, quality, and company requirements.
  • Continuously improve operating models, tools, and processes to enhance effectiveness and cross-functional collaboration.
  • Maintain high standards of scientific integrity, professionalism, patient safety, and product quality.

Benefits

  • Core and optional employee benefits are offered; details are provided at www.bscbenefitsconnect.com.
  • Exempt, non-sales roles may include an annual bonus target and long-term incentives, subject to plan eligibility and other requirements.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service